Navigation Links
Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care
Date:4/28/2009

Shared Physicians, Diagnosis, Locations, and Research Benefit Regional Cancer Patients

NEW ORLEANS, April 28 /PRNewswire/ -- Ochsner Health System (www.ochsner.org) and LSU Health Sciences Center, New Orleans (www.lsuhsc.edu) have announced a partnership to better serve the region's cancer patients by combining clinical care and cancer research in order to advance patient treatment options and provide better access to care. This collaboration will also further the development of critical, translational research, bridging the gap between research and the delivery of new therapies by allowing research to move rapidly from the laboratory into additional early phase clinical trials and new treatments for cancer patients.

The partnership between the two medical leaders began in 2008 and is centered on combining LSUHSC, the state's largest cancer research facility, with Ochsner, the state's largest clinical cancer provider, to bring better local access to comprehensive cancer care. Patients will benefit from this partnership by having access to the latest research trials and treatments closer to home and the ability to receive comprehensive cancer care through a combined network of local physicians and neighborhood locations. LSUHSC and Ochsner patients will have access to cancer services at both organizations.

"Southeast Louisiana residents will now have a truly diverse 'team' of cancer care experts, clinical experts and research leaders, dedicated to providing compassionate and comprehensive cancer care within the local community," said Dr. John Cole, M.D., Head of Hematology/Oncology at Ochsner Medical Center and Acting Chief of Hematology/Oncology at LSU Health Sciences Center New Orleans. "By combining our expertise, patients will no longer have to travel outside Louisiana to get the most current cancer treatments or participate in potentially lifesaving clinical trials."

"The joint program will allow scientists and clinicians to jointly study the most frequent cancers in our region and design new ways to prevent, diagnose and treat them," notes Dr. Augusto Ochoa, Director of the LSUHSC Stanley S. Scott Cancer Center.

"This partnership was developed from mutual commitment to provide the best care for our communities. Ochsner and LSUHSC have a long tradition of partnership through shared medical education and research trials; however, this latest collaboration will have a more direct impact on residents lives," explains Warner Thomas, President and Chief Operating Officer of Ochsner Health System.

"LSU Health Sciences Center and Ochsner have a number of joint training programs for resident physicians," said Dr. Larry Hollier, Chancellor of LSU Health Sciences Center New Orleans. "This new initiative in clinical cancer care will expand the ability of both institutions to provide the latest diagnosis and treatment for a broad range of cancer patients. This is an important milestone in the recovery of health care services for people in the New Orleans area."


'/>"/>
SOURCE Ochsner Health System
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
2. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
6. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
7. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
9. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
10. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
11. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017  Trovagene, Inc. (NASDAQ: TROV), a precision ... Officer, Bill Welch , will be presenting at ... 9:00 AM EDT at the Essex House in ... Chief Scientific Officer, Mark Erlander , Ph.D., will ... conference.   The presentation will be webcast live ...
(Date:3/27/2017)... 2017 Neurotrope, Inc. (OTCQB: NTRP),  a ... diseases, including Alzheimer,s disease, today announced that it ... the Company,s common stock on the NASDAQ Capital ... Market, a unit of the NASDAQ OMX Group. ... Opening Bell at the NASDAQ MarketSite in Times ...
(Date:3/24/2017)... and ROCKVILLE, Md. , ... company of Maxwell Biotech Venture Fund (MBVF), today announced ... SQ109 added to the standard drug therapy regimen in ... new small molecule drug discovered by scientists at Sequella, ... National Institutes of Health. A total ...
(Date:3/24/2017)... Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of ... its board of directors has amended its shareholder rights plan. The amendment ... to March 27, 2018. The amendment was not in response to any ... ... is a China -based biopharmaceutical company that focuses ...
Breaking Biology Technology:
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader ... its elite iris biometric solution on the latest ... LTE at Mobile World Congress 2017 (February ... Booth in Hall 3, Stand 3E10. ... Qualcomm Haven™ security platform—a combination of hardware, ...
Breaking Biology News(10 mins):